MetLife Investment Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

MetLife Investment Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,002	Closed	-$128K	–	2428
2019 Q2	$128K	Hold	1,002	–	–	﹤0.01%	2270
2019 Q1	$181K	Hold	1,002	–	–	﹤0.01%	2026
2018 Q4	$111K	Buy	+1,002	New	+$131K	﹤0.01%	2246
2018 Q3	–	Sell	-945	Closed	-$130K	–	2640
2018 Q2	$130K	Hold	945	–	–	﹤0.01%	2125
2018 Q1	$130K	Buy	945 +672	+246%	+$91.5K	﹤0.01%	2104
2017 Q4	$34K	Buy	+273	New	+$37.5K	﹤0.01%	2218

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MetLife Investment Management's SRGA Position: Q3 2019 in Review

MetLife Investment Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2019, closing a stake of 1,002 shares — an estimated $128K sold.

MetLife Investment Management first reported a position in SRGA in Q4 2017 and held it in 6 quarters. The position peaked at $181K in Q1 2019. 97 funds tracked by Wall St. Rank hold SRGA as of Q3 2019.

MetLife Investment Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
MetLife Investment Management sold 1,002 Surgalign Holdings, Inc. Common Stock shares in Q3 2019, an estimated $128K.
MetLife Investment Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
MetLife Investment Management's Surgalign Holdings, Inc. Common Stock position peaked at $181K in Q1 2019.
97 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2019.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.